DAHANCA: Difference between revisions
No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
{{SIB}} | {{SIB}} | ||
[[Category: Medical terms]] | [[Category: Medical terms]] | ||
[[Category: Cancer research]] | |||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 13:32, 4 May 2009
WikiDoc Resources for DAHANCA |
Articles |
---|
Most recent articles on DAHANCA |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on DAHANCA at Clinical Trials.gov Clinical Trials on DAHANCA at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on DAHANCA
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating DAHANCA Risk calculators and risk factors for DAHANCA
|
Healthcare Provider Resources |
Causes & Risk Factors for DAHANCA |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
DAHANCA refers to the "Danish Head and Neck Cancer Study". It actually refers to a series of studies, the most recent of which is "DAHANCA 10". Other notable studies include DAHANCA 5[1] and DAHANCA 6/7.[2]
It operates under the authority of the Danish Society for Head and Neck Oncology.
See also
References
- ↑ Eriksen JG, Overgaard J (2007). "Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: An evaluation of the DAHANCA 5 study>". doi:10.1016/j.radonc.2007.05.009. PMID 17543403.
- ↑ Overgaard J, Hansen HS, Specht L; et al. (2003). "Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial". Lancet. 362 (9388): 933–40. PMID 14511925.